Qing-Yun Wu

Dr. Qing-Yun Wu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
LFLin Fu
Lin Fu
HFHuaping Fu
Huaping Fu
QWQing-Yun Wu
Qing-Yun Wu
YPYifan Pang
Yifan Pang
KXKeman Xu
Keman Xu
JSJinlong Shi
Jinlong Shi
ETS2 is a downstream effector of the RAS/RAF/ERK pathway, which plays a critical role in the development of malignant tumor. However, the clinical impact of ETS2 expression in AML remains unknown. In this study, we evaluated the prognostic significance of ETS2 expression using two relatively large cohorts of AML patients. In the first cohort, compared to low expression of ETS2 (ETS2 low), high expression of ETS2 (ETS2 high) showed significant shorter OS, EFS and RFS in the current treatments including the allogeneic HCT group (n = 72) and the chemotherapy group (n = 100). Notably, among ETS2 high patients, those received allogeneic HCT had longer OS, EFS and RFS than those with chemotherapy alone (allogeneic HCT, n = 39 vs. chemotherapy, n = 47), but treatment modules play insignificant role in the survival of ETS2 low patients (allogeneic HCT, n = 33 vs. chemotherapy, n = 53). Moreover, gene/microRNA expression data provides insights into the biological changes associated with varying ETS2 expression levels in AML. The prognostic value of ETS2 was further validated in the second AML cohort (n = 329). Our results indicate that ETS2 high is a poor prognostic factor in AML and may guide treatment decisions towards allogeneic HCT.

16 August 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
XMXing-Ru Mu
Xing-Ru Mu
MMMeng-Meng Ma
Meng-Meng Ma
ZLZi-Yi Lu
Zi-Yi Lu
JLJun Liu
Jun Liu
YXYu-Tong Xue
Yu-Tong Xue
QWQing-Yun Wu
Qing-Yun Wu
Polo-like kinase 4 (PLK4), a key regulator of centriole biogenesis, is frequently overexpressed in cancer cells. However, roles and the mechanism of PLK4 in the leukemiagenesis of acute myeloid leukemia (AML) remain unclear. In this study, the PLK4 inhibitor Centrinone and the shRNA knockdown were used to investigate roles and the mechanism of PLK4 in the leukemiagenesis of AML. Our results indicated that Centrinone inhibited the proliferation of AML cells in a dose- and time-dependent manner via reduced the expression of PLK4 both in the protein and mRNA levels. Moreover, colony formation assay revealed that Centrinone reduced the number and the size of the AML colonies. Centrinone induced AML cell apoptosis by increasing the activation of Caspase-3/poly ADP-ribose polymerase (PARP). Notably, Centrinone caused the G2/M phase cell cycle arrest by decreasing the expression of cell cycle-related proteins such as Cyclin A2, Cyclin B1, and Cyclin-dependent kinase 1 (CDK1). Consistent with above results, knockdown the expression of PLK4 also inhibited cell proliferation and colony formation, induced cell apoptosis, and caused G2/M phase cell cycle arrest without affecting cell differentiation. All in all, this study suggested that PLK4 inhibited the progression of AML in vitro, and these results herein may provide clues in roles of PLK4 in the leukemiagenesis of AML.

21 July 2015 in Thrombosis Research
Verified
Journal Article
Closed access
PDF file
FZFeng Zhu
Feng Zhu
JQJianlin Qiao
Jianlin Qiao
JCJiang Cao
Jiang Cao
HSHai-Ying Sun
Hai-Ying Sun
QWQing-Yun Wu
Qing-Yun Wu
KXKailin Xu
Kailin Xu

1 August 2015 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
FLFeng Li
Feng Li
WLWei Li
Wei Li
YLYang Liu
Yang Liu
YTYu-Xue Tong
Yu-Xue Tong
PZPing Zhou
Ping Zhou
KXKailin Xu
Kailin Xu

1 December 2012 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
QWQing-Yun Wu
Qing-Yun Wu
FLFeng Li
Feng Li
HGHua-Yan Guo
Hua-Yan Guo
JCJiang Cao
Jiang Cao
CCChong Chen
Chong Chen
KXKai-Lin Xu
Kai-Lin Xu

1 September 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
CCChong Chen
Chong Chen
FLFeng Li
Feng Li
MMMeng-Meng Ma
Meng-Meng Ma
SZSen Zhang
Sen Zhang
YLYang Liu
Yang Liu
QWQing-Yun Wu
Qing-Yun Wu